Search

everythinglearnresearchcommunity

for

Search:↓

Women with thinning hair have thinner hair strands than women without hair loss.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

A systematic approach is crucial for managing hair loss in women.

Most types of hair loss can regrow naturally, but there are no effective cures for male pattern or age-related hair loss, and only limited options for females.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Oral contraceptives may cause hair loss in women.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Senescent alopecia is a type of hair loss that occurs after age 50, not caused by genetics, and involves a gradual thinning of hair without significant inflammation.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Hair loss increases between July and October, possibly due to UV light, and factors like skin type, hair color, and density may affect this. Dandruff can worsen hair loss conditions.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Minoxidil promotes hair growth in women with early-stage alopecia.

TrichoScan is a reliable method for measuring hair growth and is useful for assessing hair loss treatments.

Hair and scalp disorders significantly affect self-esteem, and using cosmetic products like conditioners and styling aids can improve hair health and appearance.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.